CD8A and neoplasm: Within tumor microenvironment, CD73−/− hosts with anti-4-1BB treatment recruited the greatest number of T cells especially CD8+ T cells compared with other groups (Fig. 1c, d and Supplementary Fig. 1), indicating that B16-reactive CD8+ T cells may be accumulating in the tumor.